Ueki M, Yokono S, Komatsu H, Ogli K
Department of Anesthesiology and Emergency Medicine, Kagawa Medical School.
Masui. 1995 Apr;44(4):570-3.
The principal perioperative management of patients with renal dysfunction is to prevent postoperative acute renal failure. Therefore, it is crucial to do all possible therapies by which its occurrence is prevented. We experienced three cases in which ulinastatin may have been beneficial to maintain postoperative renal function. The patients had preoperative renal dysfunction with serum Cr between 1.5 and 2.0 mg.dl-1. During the operation and for the three postoperative days, 300,000 units.day-1 of ulinastatin were administered intravenously. After the operation, serum Cr level was not elevated. Urine output and creatinine clearance increased. These three clinical cases suggest that ulinastatin may prevent the deterioration of postoperative renal function in patient with preoperative renal dysfunction.
肾功能不全患者围手术期的主要管理目标是预防术后急性肾衰竭。因此,采取一切可能的治疗措施以预防其发生至关重要。我们遇到了三例患者,在这些病例中,乌司他丁可能有助于维持术后肾功能。这些患者术前存在肾功能不全,血清肌酐水平在1.5至2.0mg·dl⁻¹之间。手术期间及术后三天,静脉注射乌司他丁30万单位/天。术后,血清肌酐水平未升高。尿量和肌酐清除率增加。这三例临床病例表明,乌司他丁可能预防术前肾功能不全患者术后肾功能的恶化。